Invivo Therapeutics Holdings Corp Company Profile (OTCMKTS:NVIV)

About Invivo Therapeutics Holdings Corp

Invivo Therapeutics Holdings Corp logoInVivo Therapeutics Holdings Corp., formerly Design Source, Inc., is a research and clinical-stage biomaterials and biotechnology company. The Company is engaged in developing and commercializing biopolymer-scaffolding devices for the treatment of spinal cord injuries (SCI). The Company's approach to treating acute SCIs is based on its investigational Neuro Spinal Scaffold implant, an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord contusion and is intended to treat acute spinal cord injury. The Neuro-Spinal Scaffold consists of biocompatible and bioresorbable polymers, which include poly lactic-co-glycolic acid (PLGA) and Poly-L-Lysine (PLL). The Company is also evaluating other technologies and therapeutics that may be complementary to its development of the Neuro-Spinal Scaffold implant. The Company has a clinical development program for acute SCI and a preclinical development program for chronic SCI.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: NVIV
  • CUSIP:
Key Metrics:
  • Previous Close: $4.50
  • 50 Day Moving Average: $4.48
  • 200 Day Moving Average: $5.28
  • 52-Week Range: $4.00 - $10.36
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.92
  • P/E Growth: 0.00
  • Market Cap: $144.15M
  • Outstanding Shares: 32,033,000,000
Additional Links:
Companies Related to Invivo Therapeutics Holdings Corp:

Analyst Ratings

Consensus Ratings for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) (?)
Ratings Breakdown: 2 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.33)
Consensus Price Target: $20.42

Analysts' Ratings History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
Show:
DateFirmActionRatingPrice TargetDetails
7/21/2016Ladenburg Thalmann Financial ServicesInitiated CoverageBuy$23.25View Rating Details
7/7/2016Raymond James Financial, Inc.Initiated CoverageStrong-Buy$13.00View Rating Details
5/12/2016HC WainwrightReiterated RatingBuyView Rating Details
(Data available from 2/22/2015 forward)

Earnings

Earnings History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/2/2017        
11/4/2016Q3($0.20)($0.18)ViewN/AView Earnings Details
5/6/2016($0.26)($0.20)ViewN/AView Earnings Details
8/5/2015($0.20)($0.39)ViewN/AView Earnings Details
5/7/2015($0.05)($0.64)ViewN/AView Earnings Details
3/11/2015($0.04)($0.09)ViewN/AView Earnings Details
11/5/2014($0.05)($0.01)ViewN/AView Earnings Details
8/6/2014($0.06)($0.04)ViewN/AView Earnings Details
5/12/2014($0.08)($0.07)ViewN/AView Earnings Details
3/17/2014($0.08)($0.06)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
Current Year EPS Consensus Estimate: $-0.78 EPS
Next Year EPS Consensus Estimate: $-0.76 EPS

Dividends

Dividend History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2014Francis ReynoldsMajor ShareholderSell50,000$1.20$60,000.00View SEC Filing  
5/5/2014Francis ReynoldsMajor ShareholderSell37,500$1.87$70,125.00View SEC Filing  
4/30/2014Francis ReynoldsMajor ShareholderSell37,500$1.82$68,250.00View SEC Filing  
4/25/2014Francis ReynoldsMajor ShareholderSell50,000$1.52$76,000.00View SEC Filing  
4/21/2014Francis ReynoldsMajor ShareholderSell50,000$1.57$78,500.00View SEC Filing  
4/14/2014Francis ReynoldsMajor ShareholderSell37,500$1.63$61,125.00View SEC Filing  
4/9/2014Francis ReynoldsMajor ShareholderSell37,500$1.60$60,000.00View SEC Filing  
4/4/2014Francis ReynoldsMajor ShareholderSell25,000$1.71$42,750.00View SEC Filing  
4/2/2014Francis ReynoldsMajor ShareholderSell37,500$1.71$64,125.00View SEC Filing  
3/26/2014Francis ReynoldsMajor ShareholderSell47,900$1.80$86,220.00View SEC Filing  
3/21/2014Francis ReynoldsMajor ShareholderSell39,600$2.15$85,140.00View SEC Filing  
3/17/2014Francis ReynoldsMajor ShareholderSell37,500$2.44$91,500.00View SEC Filing  
3/12/2014Francis ReynoldsMajor ShareholderSell37,500$2.33$87,375.00View SEC Filing  
3/7/2014Francis ReynoldsMajor ShareholderSell25,000$2.44$61,000.00View SEC Filing  
3/5/2014Francis ReynoldsMajor ShareholderSell37,500$2.49$93,375.00View SEC Filing  
2/28/2014Francis ReynoldsMajor ShareholderSell25,000$2.44$61,000.00View SEC Filing  
2/26/2014Francis ReynoldsMajor ShareholderSell37,500$2.28$85,500.00View SEC Filing  
2/21/2014Francis ReynoldsMajor ShareholderSell25,000$2.23$55,750.00View SEC Filing  
2/19/2014Francis ReynoldsMajor ShareholderSell25,000$2.25$56,250.00View SEC Filing  
2/14/2014Francis ReynoldsMajor ShareholderSell25,000$2.24$56,000.00View SEC Filing  
2/12/2014Francis ReynoldsMajor ShareholderSell37,500$2.25$84,375.00View SEC Filing  
2/7/2014Francis ReynoldsMajor ShareholderSell25,000$2.23$55,750.00View SEC Filing  
2/5/2014Francis ReynoldsMajor ShareholderSell37,500$2.21$82,875.00View SEC Filing  
1/31/2014Francis ReynoldsMajor ShareholderSell25,000$2.17$54,250.00View SEC Filing  
1/29/2014Francis ReynoldsMajor ShareholderSell37,500$2.22$83,250.00View SEC Filing  
1/24/2014Francis ReynoldsMajor ShareholderSell25,000$2.25$56,250.00View SEC Filing  
1/21/2014Francis ReynoldsMajor ShareholderSell37,500$2.36$88,500.00View SEC Filing  
1/15/2014Francis ReynoldsMajor ShareholderSell37,500$2.22$83,250.00View SEC Filing  
1/10/2014Francis ReynoldsMajor ShareholderSell48,000$2.41$115,680.00View SEC Filing  
1/6/2014Francis ReynoldsMajor ShareholderSell36,000$2.28$82,080.00View SEC Filing  
12/31/2013Francis ReynoldsMajor ShareholderSell36,000$2.25$81,000.00View SEC Filing  
12/26/2013Francis ReynoldsMajor ShareholderSell36,000$1.99$71,640.00View SEC Filing  
12/20/2013Francis ReynoldsMajor ShareholderSell24,000$1.96$47,040.00View SEC Filing  
12/18/2013Francis ReynoldsMajor ShareholderSell36,000$1.90$68,400.00View SEC Filing  
12/13/2013Francis ReynoldsMajor ShareholderSell24,000$1.80$43,200.00View SEC Filing  
12/11/2013Francis ReynoldsMajor ShareholderSell36,000$1.75$63,000.00View SEC Filing  
12/6/2013Francis ReynoldsMajor ShareholderSell24,000$1.59$38,160.00View SEC Filing  
12/4/2013Francis ReynoldsMajor ShareholderSell36,000$1.90$68,400.00View SEC Filing  
11/22/2013Francis ReynoldsMajor ShareholderSell24,000$1.92$46,080.00View SEC Filing  
11/20/2013Francis ReynoldsMajor ShareholderSell36,000$1.95$70,200.00View SEC Filing  
11/13/2013Francis ReynoldsMajor ShareholderSell36,000$1.14$41,040.00View SEC Filing  
11/8/2013Francis ReynoldsMajor ShareholderSell24,000$1.11$26,640.00View SEC Filing  
11/6/2013Francis ReynoldsMajor ShareholderSell36,000$1.16$41,760.00View SEC Filing  
11/1/2013Francis ReynoldsMajor ShareholderSell24,000$1.16$27,840.00View SEC Filing  
10/30/2013Francis ReynoldsMajor ShareholderSell36,000$1.23$44,280.00View SEC Filing  
10/25/2013Francis ReynoldsMajor ShareholderSell24,000$1.35$32,400.00View SEC Filing  
10/22/2013Francis ReynoldsMajor ShareholderSell24,000$1.40$33,600.00View SEC Filing  
10/18/2013Francis ReynoldsMajor ShareholderSell24,000$1.45$34,800.00View SEC Filing  
10/16/2013Francis ReynoldsMajor ShareholderSell36,000$1.49$53,640.00View SEC Filing  
10/11/2013Francis ReynoldsMajor ShareholderSell24,000$1.51$36,240.00View SEC Filing  
10/9/2013Francis ReynoldsMajor ShareholderSell36,000$1.41$50,760.00View SEC Filing  
10/4/2013Francis ReynoldsMajor ShareholderSell24,000$1.41$33,840.00View SEC Filing  
9/20/2013Francis ReynoldsMajor ShareholderSell24,000$1.37$32,880.00View SEC Filing  
9/18/2013Francis ReynoldsMajor ShareholderSell36,000$1.43$51,480.00View SEC Filing  
9/13/2013Francis ReynoldsMajor ShareholderSell24,000$1.50$36,000.00View SEC Filing  
9/11/2013Francis ReynoldsMajor ShareholderSell24,000$1.72$41,280.00View SEC Filing  
9/6/2013Francis ReynoldsMajor ShareholderSell24,000$1.61$38,640.00View SEC Filing  
9/4/2013Francis ReynoldsMajor ShareholderSell24,000$1.36$32,640.00View SEC Filing  
9/3/2013Sean F MoranCFOBuy20,000$1.02$20,400.00View SEC Filing  
8/30/2013Francis ReynoldsMajor ShareholderSell9,200$1.55$14,260.00View SEC Filing  
8/30/2013Sean F MoranCFOBuy40,000$1.30$52,000.00View SEC Filing  
8/28/2013Francis ReynoldsMajor ShareholderSell12,600$3.24$40,824.00View SEC Filing  
8/23/2013Francis ReynoldsMajor ShareholderSell21,300$4.07$86,691.00View SEC Filing  
8/21/2013Francis ReynoldsCEOSell36,000$4.12$148,320.00View SEC Filing  
8/16/2013Francis ReynoldsCEOSell24,000$4.24$101,760.00View SEC Filing  
8/14/2013Francis ReynoldsCEOSell36,000$4.34$156,240.00View SEC Filing  
8/9/2013Francis ReynoldsCEOSell24,000$4.42$106,080.00View SEC Filing  
8/7/2013Francis ReynoldsCEOSell36,000$4.46$160,560.00View SEC Filing  
8/2/2013Francis ReynoldsCEOSell24,000$4.57$109,680.00View SEC Filing  
7/30/2013Francis ReynoldsCEOSell24,000$5.11$122,640.00View SEC Filing  
7/26/2013Francis ReynoldsCEOSell24,000$5.29$126,960.00View SEC Filing  
7/24/2013Francis ReynoldsCEOSell36,000$5.72$205,920.00View SEC Filing  
7/19/2013Francis ReynoldsCEOSell24,000$5.27$126,480.00View SEC Filing  
7/17/2013Francis ReynoldsCEOSell36,000$5.12$184,320.00View SEC Filing  
7/12/2013Francis ReynoldsCEOSell24,000$4.43$106,320.00View SEC Filing  
7/10/2013Francis ReynoldsCEOSell36,000$3.97$142,920.00View SEC Filing  
7/5/2013Francis ReynoldsCEOSell12,000$4.00$48,000.00View SEC Filing  
7/3/2013Francis ReynoldsCEOSell36,000$4.08$146,880.00View SEC Filing  
6/28/2013Francis ReynoldsCEOSell24,000$4.22$101,280.00View SEC Filing  
6/26/2013Francis ReynoldsCEOSell36,000$3.87$139,320.00View SEC Filing  
6/21/2013Francis ReynoldsCEOSell24,000$3.78$90,720.00View SEC Filing  
6/19/2013Francis ReynoldsCEOSell36,000$3.89$140,040.00View SEC Filing  
6/14/2013Francis ReynoldsCEOSell24,000$3.84$92,160.00View SEC Filing  
6/12/2013Francis ReynoldsCEOSell12,750$4.34$55,335.00View SEC Filing  
6/7/2013Francis ReynoldsCEOSell8,500$4.02$34,170.00View SEC Filing  
6/5/2013Francis ReynoldsCEOSell12,750$3.75$47,812.50View SEC Filing  
6/5/2013Robert LangerMajor ShareholderSell7,500$3.73$27,975.00View SEC Filing  
5/31/2013Francis ReynoldsCEOSell8,500$3.32$28,220.00View SEC Filing  
5/31/2013Robert LangerMajor ShareholderSell7,500$3.31$24,825.00View SEC Filing  
5/29/2013Francis ReynoldsCEOSell8,500$3.13$26,605.00View SEC Filing  
5/28/2013Robert LangerMajor ShareholderSell7,500$2.97$22,275.00View SEC Filing  
5/24/2013Francis ReynoldsCEOSell8,500$2.95$25,075.00View SEC Filing  
5/22/2013Robert LangerMajor ShareholderSell7,500$2.88$21,600.00View SEC Filing  
5/21/2013Francis ReynoldsCEOSell12,750$2.88$36,720.00View SEC Filing  
5/17/2013Francis ReynoldsCEOSell8,500$2.87$24,395.00View SEC Filing  
5/17/2013Robert LangerMajor ShareholderSell7,500$2.85$21,375.00View SEC Filing  
5/15/2013Francis ReynoldsCEOSell12,750$2.89$36,847.50View SEC Filing  
5/14/2013Robert LangerMajor ShareholderSell7,500$2.91$21,825.00View SEC Filing  
5/10/2013Francis ReynoldsCEOSell8,500$2.92$24,820.00View SEC Filing  
5/9/2013Robert LangerMajor ShareholderSell7,500$2.91$21,825.00View SEC Filing  
4/12/2013Francis ReynoldsCEOSell8,500$3.16$26,860.00View SEC Filing  
2/5/2013Francis ReynoldsCEOSell12,750$2.03$25,882.50View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)
DateHeadline
News IconInvestor Alert: Invivo Therapeutics Holdings Corp (NYSE:NVIV) Price Target Update - Rockville Register (OTCMKTS:NVIV)
rockvilleregister.com - February 21 at 5:58 PM
News IconSell-side Review & Stock Update on Invivo Therapeutics Holdings Corp (NYSE:NVIV) - Rockville Register (OTCMKTS:NVIV)
rockvilleregister.com - February 19 at 9:38 AM
seekingalpha.com logoInVivo Therapeutics Holdings (NVIV) Presents at 19th Annual BIO CEO & Investor Conference (OTCMKTS:NVIV)
seekingalpha.com - February 14 at 10:08 PM
News IconFanning the Flames: Increased Volatility Noted on Shares of InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - Davidson Register (OTCMKTS:NVIV)
davidsonregister.com - February 7 at 4:29 PM
businesswire.com logoInVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - February 7 at 4:29 PM
finance.yahoo.com logoInVivo Therapeutics to Present at 2017 BIO CEO & Investor Conference (OTCMKTS:NVIV)
finance.yahoo.com - February 7 at 9:16 AM
News IconPixarBio Investor Loss Alert: Hagens Berman Alerts Investors in PixarBio Corporation to Securities Class Action and Lead Plaintiff Deadline (OTCMKTS:NVIV)
forextv.com - February 6 at 7:01 PM
businesswire.com logoINVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of PixarBio Corporation Investors (OTCMKTS:NVIV)
www.businesswire.com - February 2 at 7:50 PM
prnewswire.com logoPixarBio Corporation Sued By Block & Leviton For Violations Of The Federal Securities Laws (OTCMKTS:NVIV)
www.prnewswire.com - January 31 at 5:42 AM
News IconSell-side is Weighing in on Invivo Therapeutics Holdings Corp (NYSE:NVIV) Earnings & Targets - Aiken Advocate (OTCMKTS:NVIV)
aikenadvocate.com - January 30 at 7:38 PM
News IconChecking the Levels on Shares of InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - The Tribune (OTCMKTS:NVIV)
lakecitytribune.com - January 30 at 7:38 PM
News IconStock Tracker: Earnings & Estimates for Invivo Therapeutics Holdings Corp (NYSE:NVIV) - Aiken Advocate (OTCMKTS:NVIV)
aikenadvocate.com - January 29 at 12:04 AM
prnewswire.com logoRM LAW Announces Class Action Lawsuit Against PixarBio Corporation (OTCMKTS:NVIV)
www.prnewswire.com - January 28 at 5:16 AM
tmcnet.com logoGlancy Prongay & Murray LLP Commences Investigation on Behalf of PixarBio Corporation Investors (OTCMKTS:NVIV)
www.tmcnet.com - January 26 at 11:43 PM
seekingalpha.com logoInVivo Therapeutics Holdings Corp (NVIV) (OTCMKTS:NVIV)
seekingalpha.com - January 26 at 11:43 PM
finance.yahoo.com logoPixarBio Corporation Investigated For Securities Fraud By Block & Leviton Following Suspension In Trading By SEC (OTCMKTS:NVIV)
finance.yahoo.com - January 25 at 10:09 PM
investopedia.com logoInVivo Gains on Neuro-Spinal Scaffold Results (NVIV) (OTCMKTS:NVIV)
www.investopedia.com - January 25 at 10:09 PM
investopedia.com logoInVivo Gains on Neuro-Spinal Scaffold Results (OTCMKTS:NVIV)
www.investopedia.com - January 25 at 10:09 PM
News IconFanning the Flames: Increased Volatility Noted on Shares of InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - Wall Street Beacon (OTCMKTS:NVIV)
wsbeacon.com - January 25 at 5:47 AM
businesswire.com logoInVivo Therapeutics Announces Sixth Patient Conversion in The ... - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - January 25 at 5:47 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PixarBio Corporation - PXRB (OTCMKTS:NVIV)
finance.yahoo.com - January 24 at 7:43 PM
finance.yahoo.com logoHere's Why InVivo Therapeutics is Gaining Today (OTCMKTS:NVIV)
finance.yahoo.com - January 24 at 7:42 PM
us.rd.yahoo.com logoInVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™ (OTCMKTS:NVIV)
us.rd.yahoo.com - January 24 at 9:04 AM
News IconSteering Attention Towards Earnings; Analysts Weigh in on Invivo Therapeutics Holdings Corp (NYSE:NVIV) Stock - Aiken Advocate (OTCMKTS:NVIV)
aikenadvocate.com - January 23 at 7:18 PM
bizjournals.com logoSEC halts trading in PixarBio amid concerns over stock manipulation (OTCMKTS:NVIV)
www.bizjournals.com - January 23 at 7:18 PM
News IconStock Backsliding Ahead of the Bell, Gapping Down: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - Aiken Advocate (OTCMKTS:NVIV)
aikenadvocate.com - January 19 at 12:36 AM
businesswire.com logoInVivo Therapeutics Announces University of New Mexico Hospital as New Site for INSPIRE Study - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - January 19 at 12:36 AM
finance.yahoo.com logoInVivo Therapeutics Featured in Nationally Syndicated Radio Segment (OTCMKTS:NVIV)
finance.yahoo.com - January 18 at 9:06 AM
finance.yahoo.com logoInVivo Therapeutics Announces University of New Mexico Hospital as New Site for INSPIRE Study (OTCMKTS:NVIV)
finance.yahoo.com - January 17 at 11:24 AM
News IconMarkets End Mostly Higher, How Did This Stock Fare: InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - Wall Street Beacon (OTCMKTS:NVIV)
wsbeacon.com - January 14 at 7:02 PM
News IconInVivo Therapeutics Announces INSPIRE'S 29th Clinical Site ... - OrthoSpineNews (OTCMKTS:NVIV)
www.orthospinenews.com - January 12 at 12:36 AM
seekingalpha.com logoThe Backdrop For PixarBio's Offer To Acquire InVivo Therapeutics - Seeking Alpha (OTCMKTS:NVIV)
seekingalpha.com - January 12 at 12:36 AM
law360.com logo1st Circ. Won't Revive Spinal Therapy Co. Investor Suit (OTCMKTS:NVIV)
www.law360.com - January 10 at 7:48 PM
tmcnet.com logoInVivo Therapeutics Announces INSPIRE'S 29th Clinical Site: Rhode Island Hospital (OTCMKTS:NVIV)
www.tmcnet.com - January 10 at 7:48 PM
businesswire.com logoInVivo Therapeutics Announces INSPIRE'S 29th Clinical Site: Rhode Island Hospital - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - January 10 at 8:47 AM
finance.yahoo.com logoInVivo Therapeutics Announces INSPIRE’S 29th Clinical Site: Rhode Island Hospital (OTCMKTS:NVIV)
finance.yahoo.com - January 10 at 8:47 AM
marketexclusive.com logoINVIVO THERAPEUTICS HOLDINGS CORP. (NASDAQ:NVIV) Files An 8-K Regulation FD Disclosure - Market Exclusive (OTCMKTS:NVIV)
marketexclusive.com - January 10 at 12:40 AM
reuters.com logoBRIEF-U.S. appeals court upholds dismissal of InVivo Therapeutics shareholder lawsuit (OTCMKTS:NVIV)
www.reuters.com - January 9 at 7:38 PM
4-traders.com logoINVIVO THERAPEUTICS HOLDINGS CORP. (NASDAQ:NVIV) Files An 8-K Regulation FD Disclosure (OTCMKTS:NVIV)
www.4-traders.com - January 9 at 7:38 PM
us.rd.yahoo.com logoInVivo Therapeutics Announces St. Michael’s Hospital as New Canadian Site for INSPIRE Study (OTCMKTS:NVIV)
us.rd.yahoo.com - January 9 at 7:38 PM
bloomberg.com logoCompany Overview of InVivo Therapeutics Holdings Corp., Prior To Reverse Merger with InVivo Therapeutics Corporation (OTCMKTS:NVIV)
www.bloomberg.com - January 8 at 6:38 PM
investopedia.com logoPixarBio Makes $77 Million Bid For InVivo (NVIV) (OTCMKTS:NVIV)
www.investopedia.com - January 5 at 10:45 PM
investopedia.com logoPixarBio Offers to Acquire InVivo for $77 Million (OTCMKTS:NVIV)
www.investopedia.com - January 5 at 10:45 PM
bizjournals.com logo​With Trumpian flair, former CEO of InVivo announces unsolicited takeover offer (OTCMKTS:NVIV)
www.bizjournals.com - January 4 at 7:44 PM
reuters.com logoBRIEF-Invivo Therapeutics says has not discussed offer with PixarBio (OTCMKTS:NVIV)
www.reuters.com - January 3 at 11:15 PM
streetinsider.com logoInvivo Therapeutics (NVIV) Says Nature of PixarBio Offer is Not Credible (OTCMKTS:NVIV)
www.streetinsider.com - January 3 at 11:15 PM
publicnow.com logoInVivo Therapeutics Responds to PixarBio Announcement (OTCMKTS:NVIV)
www.publicnow.com - January 3 at 11:15 PM
4-traders.com logoNetworkNewsBreaks – InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) INSPIRE Study Reaches 50% Enrollment (OTCMKTS:NVIV)
www.4-traders.com - December 20 at 6:09 PM
businesswire.com logoInVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study - Business Wire (press release) (OTCMKTS:NVIV)
www.businesswire.com - December 20 at 1:05 PM
News IconValue Composite Score Update on InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) - The Business Journal (OTCMKTS:NVIV)
belmontbusinessjournal.com - December 12 at 7:04 PM

Social

What is Invivo Therapeutics Holdings Corp's stock symbol?

Invivo Therapeutics Holdings Corp trades on the OTCMKTS under the ticker symbol "NVIV."

Where is Invivo Therapeutics Holdings Corp's stock going? Where will Invivo Therapeutics Holdings Corp's stock price be in 2017?

3 brokerages have issued twelve-month price targets for Invivo Therapeutics Holdings Corp's shares. Their forecasts range from $13.00 to $25.00. On average, they expect Invivo Therapeutics Holdings Corp's stock price to reach $20.42 in the next twelve months.

When will Invivo Therapeutics Holdings Corp announce their earnings?

Invivo Therapeutics Holdings Corp is scheduled to release their next quarterly earnings announcement on Thursday, March, 2nd 2017.

How do I buy Invivo Therapeutics Holdings Corp stock?

Shares of Invivo Therapeutics Holdings Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Invivo Therapeutics Holdings Corp stock cost?

One share of Invivo Therapeutics Holdings Corp stock can currently be purchased for approximately $4.50.

Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV) Chart for Wednesday, February, 22, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)

Earnings History Chart

Earnings by Quarter for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)

Dividend History Chart

Dividend Payments by Quarter for Invivo Therapeutics Holdings Corp (OTCMKTS:NVIV)

Last Updated on 2/22/2017 by MarketBeat.com Staff